Healthcare Builders

Real-Time Clinical Decision Support

88 items · 6 phases · sepsis/early-warning CDS model readiness

Medical Imaging AI Inference

82 items · 6 phases · DICOM/PACS acquisition-speed imaging AI readiness

Surgical AI & Intraoperative Decision Support

84 items · 6 phases · sub-40ms per-frame OR-local inference readiness

Medication Safety & Adverse Drug Event Prevention

77 items · 6 phases · CPOE-embedded medication safety model readiness

HIPAA-Sovereign Ambient Clinical Documentation

77 items · 6 phases · on-prem ambient scribe, PHI-sovereign readiness

AI-assisted clinical documentation and ambient scribe

90 items · 6 phases · HTI-2 transparency & workflow-integrated scribe

Autonomous Prior Authorization

84 items · 6 phases · CMS-0057-F agentic prior auth readiness

Revenue Cycle AI & Denial Prevention

81 items · 6 phases · pre-submission denial prediction readiness

Clinical NLP & Unstructured Data Extraction

81 items · 6 phases · HIPAA-sovereign clinical NLP readiness

Patient Flow & Capacity Optimization

91 items · 6 phases · EHR-integrated capacity forecast readiness

Genomics & Precision Medicine Inference

95 items · 6 phases · clinical-grade genomic inference readiness

Predictive Readmission & Care Gap Identification

82 items · 6 phases · equity-adjusted readmission + care-gap readiness

Pharmacy Automation & Smart Formulary Management

87 items · 6 phases · CV verification & formulary ML readiness

AI-Powered Care Management & Chronic Disease Coaching

80 items · 6 phases · CCM/PCM-reimbursable LLM coaching readiness

Drug Discovery & Clinical Trial Acceleration

86 items · 6 phases · IP-sovereign drug discovery & trial acceleration

Secure Federated Research Analytics

87 items · 6 phases · federated learning across hospital sites readiness

Continuous AI monitoring of EHR streams — vitals, labs, notes, waveforms — for early warning scores under CMS/ONC HTI-2 enforcement with per-prediction audit trails.

AI-powered interpretation of CT, MRI, X-ray, ultrasound, and pathology slides at the point of acquisition — with 900+ FDA-cleared algorithms now deployed across radiology.

Real-time AI overlays on laparoscopic, robotic, and microscopic surgical video — identifying critical structures and flagging dangerous tissue planes under EU AI Act high-risk controls.

Catch dangerous drug interactions at order entry — not in the pharmacy.

Ambient AI listens to patient encounters and generates structured clinical notes in real time — on-premises inference is now a compliance imperative as OCR enforcement intensifies around cloud PHI processing.

Ambient AI documentation that stays inside your walls — compliant, auditable, and tuned to your clinical workflows as HTI-2 enforcement takes effect.

Agents that autonomously gather clinical evidence, apply payer criteria, and submit prior auth — meeting the CMS-0057-F 72-hour turnaround rule that took effect January 1, 2026.

Predict denial probability for every claim before submission — CMS-0057-F denial transparency requirements and the Change Healthcare breach reframe this as a sovereign-infrastructure problem.

Extract diagnoses, medications, procedures, and social determinants from free-text notes, pathology, and radiology narratives — with auditable, explainable pipelines required by HTI-2.

Predictive models for admissions, discharge, OR case duration, and ED demand — now a compliance-adjacent workload as CMS boarding-time penalties take effect.

AI-driven variant interpretation, drug-gene interaction, and tumor mutation burden analysis — classified as high-risk under the EU AI Act, demanding auditability and governance.

Locally trained, fairness-audited readmission and care-gap models under CMS HRRP's equity-adjusted penalty methodology (FY2026) and emerging state algorithmic accountability rules.

AI vision verification of dispensed medications and ML-driven formulary decisions — auditable, version-controlled inference under FDA March 2026 draft guidance.

LLM-driven coaching for diabetes, CHF, COPD, and CKD between visits — now directly reimbursable under CMS's expanded 2026 CCM/PCM billing codes.

Generative AI is compressing discovery timelines from years to months — AlphaFold 3, clinical-trial matching, and FDA PDUFA VII pathways are driving billion-dollar pharma platform deals.

Federated learning across hospital sites without centralizing patient data — provable on-prem governance and auditable gradient flows under the EU AI Act and FDA distributed AI/ML guidance.